RAMP1 and neoplasm: Although we retrieved similar numbers of CD8+ T cells across all three groups (Extended Data Fig. 10u), limited B16F10-OVA tumour growth (Fig. 5a) was found in mice that received the Ramp1−/− CD8+ T cells—which are not responsive to CGRP.